Article

Advanced hepatocellular carcinoma with MET-amplified contained excellent response to Crizotinib: a case report.

2023-03-08

Abstract excerpt

<h4>Background: </h4> Hepatocellular carcinoma (HCC) is one of the most lethal tumors all over the world. It’s considered with extensive heterogeneity and lacks therapeutic decision-making biomarkers. There are many novel therapeutic strategies tried to prolong the survival of advanced HCC. Next-generation sequencing (NGS) is generally used for helping treatment decision which help patient benefit from genome-dire...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 914a4498-a188-5868-ac3e-322c566b95e3
DOI: 10.21203/rs.3.rs-2618609/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Advanced hepatocellular carcinoma with MET-amplified contained excellent response to Crizotinib: a case report.DOI 10.21203/rs.3.rs-2618609/v1Read

MET-TKIs selectively inhibit growth of hepatobiliary carcinoma harboring high copy number MET amplification: 2 cases and literature reviewSemantic proximity Read

Exploration of Practical Biomarkers for Systemic Drug Therapy for Hepatocellular CarcinomaSemantic proximity Read

Clinicopathologic and Molecular Characteristics of Hepatoid Adenocarcinoma of Bladder: a case reportSemantic proximity Read

The Current State of Evaluation of Hepatocellular Carcinoma Differentiation and Treatment Response with Japanese Guidelines.Semantic proximity Read

Detection of MET gene somatic mutations in hepatocellular carcinoma of Egyptian patients using next-generation sequencing.Semantic proximity Read

Combined treatment for a rare malignant glomus tumor of the esophagus with pulmonary and liver metastases: a case report and review of literatureSemantic proximity Read

Gastric cancer patient with c-MET amplification treated with crizotinib after failed multi-line treatment: A case report and literature reviewSemantic proximity Read

Complete Response for Adding Pyrotinib to Pembrolizumab and Lenvatinib for HER2 Positive Advanced Intrahepatic CholangiocarcinomaSemantic proximity Read

HBV integration affect the efficacy of systematic drug therapy after radical resection of liver cancer: a prospective cohort studySemantic proximity Read

Pretreatment heterogeneous enhancement pattern of hepatocellular carcinoma can be new predictor for early response to lenvatinibSemantic proximity Read

Molecular Noninvasive Diagnosis of Hepatocellular Carcinoma Using Microsatellite Instability.Semantic proximity Read

MET gene as biomarker and potential therapeutic target in Ampullary cancerSemantic proximity Read